Insulet | PODD - Trade Debtors


Insulet reported $544.7M in Trade Debtors for its fiscal quarter ending in March of 2026.





Trade Debtors Change Date
Abbott USD 10.57B 171M Dec/2025
Align Technology USD 1.13B 23.36M Mar/2026
AtriCure USD 71.31M 4.66M Mar/2026
Avanos Medical USD 103M 800K Mar/2026
Baxter International USD 1.7B 310M Mar/2026
Becton, Dickinson and Co. USD 2.2B 303M Mar/2026
Boston Scientific USD 2.93B 98M Dec/2025
Cardinal Health USD 13.65B 14M Mar/2026
Cooper Companies USD 809.2M 2.1M Mar/2026
Dexcom USD 1.09B 182.1M Mar/2026
Edwards Lifesciences USD 912.1M 19.3M Dec/2025
Eli Lilly USD 21.18B 1.02B Mar/2026
Globus Medical USD 735.44M 8.23M Mar/2026
ICU Medical USD 180.52M 11.03M Dec/2025
Inogen USD 37.09M 4.11M Jun/2024
Insulet USD 544.7M 27.8M Mar/2026
Integra LifeSciences USD 264.41M 14.44M Mar/2026
J&J USD 21.33B 3.72B Dec/2025
Masimo USD 288.9M 103M Mar/2026
Medtronic USD 6.36B 30M Dec/2025
Merit Medical Systems USD 227M 3.39M Mar/2026
Roche Holding CHF 11.9B 460M Dec/2025
Solventum Corp USD 1.35B 163M Mar/2026
Stryker USD 3.57B 468M Mar/2026
Tandem Diabetes Care USD 165.49M 39.55M Dec/2025
Teleflex USD 365.53M 19.94M Mar/2026
West Pharmaceutical Services USD 685.6M 111.2M Mar/2026
Zimmer Biomet Holdings USD 1.73B 24.2M Mar/2026